🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

RecruitingPhase 4Ages 18 Years - anyAllPeking Union Medical College Hospital
NCT04650243 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study explores the feasibility of the reducing medication regimen for Ursodeoxycholic Acid(UDCA) in the treatment of primary biliary cholangitis. The participants will be distributed randomly into two experimental groups and one control group. The two experimental groups will receive reduced dosage of UDCA at different level, while the control group will receive standard dosage of UDCA. The effect of therapy will be evaluated every three months.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Satisfied the diagnostic criteria of PBC by the AASLDin 2000; * Age≥18 years * Clinical stage 2 and 3 (i.e. abnormal liver function and symptomatic phase); * Patients with improved liver biochemical index( ALP and AST≤1.5× upper limit of normal, with a normal bilirubin level) after 6 to 12 months treatment of UDCA; * Informed consent obtained. Exclusion Criteria: * Overlapped with other liver diseases (such as HBV, HCV, alcoholic cirrhosis, etc.) or serum ALT, AST more than 2 ULN; * Decompensation of liver function (Child grade B/C); * Complicated with important organ failure (such as renal insufficiency), serious infection or other serious complications; * Pregnancy, preparation for pregnancy or pregnancy Lactation, psychiatric subjects, etc.; * Participating in other clinical trials or participated in other clinical trials in three months.
💊

What it tests

  • ursodeoxycholic acid
📍

Where

1 site
Peking Union Medical College Hospital
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy